[
  {
    "ts": "2026-02-03T00:00:00+00:00",
    "headline": "AMD earnings, Netflix-Warner Bros. hearing: What to Watch",
    "summary": "Market Domination Overtime Host Josh Lipton previews several of the biggest stories to come tomorrow, Tuesday, February 3, including earnings results from companies like Advanced Micro Devices (AMD), Chipotle Mexican Grill (CMG), Pfizer (PFE), and Merck (MRK), and the Senate hearing on Netflix's (NFLX) proposed bid to acquire Warner Bros. Discovery (WBD). To watch more expert insights and analysis on the latest market action, check out more&nbsp;Market Domination Overtime.",
    "url": "https://finance.yahoo.com/video/amd-earnings-netflix-warner-bros-000000934.html",
    "source": "Yahoo Finance Video",
    "provider": "yfinance",
    "raw": {
      "id": "944ac714-6d5e-3cf9-ac3d-5262ebfd6519",
      "content": {
        "id": "944ac714-6d5e-3cf9-ac3d-5262ebfd6519",
        "contentType": "VIDEO",
        "title": "AMD earnings, Netflix-Warner Bros. hearing: What to Watch",
        "description": "<p>Market Domination Overtime Host <a data-i13n=\"cpos:1;pos:1\" href=\"https://www.yahoo.com/author/josh-lipton/\">Josh Lipton</a> previews several of the biggest stories to come tomorrow, Tuesday, February 3, including earnings results from companies like Advanced Micro Devices (<a data-i13n=\"cpos:2;pos:1\" href=\"https://finance.yahoo.com/quote/AMD\">AMD</a>), Chipotle Mexican Grill (<a data-i13n=\"cpos:3;pos:1\" href=\"https://finance.yahoo.com/quote/CMG\">CMG</a>), Pfizer (<a data-i13n=\"cpos:4;pos:1\" href=\"https://finance.yahoo.com/quote/PFE\">PFE</a>), and Merck (<a data-i13n=\"cpos:5;pos:1\" href=\"https://finance.yahoo.com/quote/MRK\">MRK</a>), and the Senate hearing on Netflix's (<a data-i13n=\"cpos:6;pos:1\" href=\"https://finance.yahoo.com/quote/NFLX\">NFLX</a>) proposed bid to acquire Warner Bros. Discovery (<a data-i13n=\"cpos:7;pos:1\" href=\"https://finance.yahoo.com/quote/WBD\">WBD</a>).</p>\n<p>To watch more expert insights and analysis on the latest market action, check out more <a data-i13n=\"cpos:8;pos:1\" href=\"https://finance.yahoo.com/videos/series/market-domination-overtime/\">Market Domination Overtime</a>.</p>",
        "summary": "Market Domination Overtime Host Josh Lipton previews several of the biggest stories to come tomorrow, Tuesday, February 3, including earnings results from companies like Advanced Micro Devices (AMD), Chipotle Mexican Grill (CMG), Pfizer (PFE), and Merck (MRK), and the Senate hearing on Netflix's (NFLX) proposed bid to acquire Warner Bros. Discovery (WBD). To watch more expert insights and analysis on the latest market action, check out more&nbsp;Market Domination Overtime.",
        "pubDate": "2026-02-03T00:00:00Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2026-02/67792e30-0073-11f1-bfff-3c4891fc6d0b",
          "originalWidth": 1920,
          "originalHeight": 1080,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UzqQCDUXj0MPW_tlpZ7E0A--~B/aD0xMDgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2026-02/67792e30-0073-11f1-bfff-3c4891fc6d0b.cf.webp",
              "width": 1920,
              "height": 1080,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/n0CeAGm.cJ44Rdq8zCs3Mw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2026-02/67792e30-0073-11f1-bfff-3c4891fc6d0b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance Video",
          "url": "https://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/amd-earnings-netflix-warner-bros-000000934.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/amd-earnings-netflix-warner-bros-000000934.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NFLX"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "PYPL"
            },
            {
              "symbol": "CMG"
            },
            {
              "symbol": "WBD"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T01:54:26+00:00",
    "headline": "C4 Therapeutics, Inc. (CCCC): A Bull Case Theory",
    "summary": "We came across a bullish thesis on C4 Therapeutics, Inc. on Ridire Research’s Substack. In this article, we will summarize the bulls’ thesis on CCCC. C4 Therapeutics, Inc.’s share was trading at $1.9600 as of January 29th. C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins, stands at the forefront of targeted protein […]",
    "url": "https://finance.yahoo.com/news/c4-therapeutics-inc-cccc-bull-015426512.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "a0b6e7e9-464d-36f0-b72d-7146e5449f6a",
      "content": {
        "id": "a0b6e7e9-464d-36f0-b72d-7146e5449f6a",
        "contentType": "STORY",
        "title": "C4 Therapeutics, Inc. (CCCC): A Bull Case Theory",
        "description": "",
        "summary": "We came across a bullish thesis on C4 Therapeutics, Inc. on Ridire Research’s Substack. In this article, we will summarize the bulls’ thesis on CCCC. C4 Therapeutics, Inc.’s share was trading at $1.9600 as of January 29th. C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins, stands at the forefront of targeted protein […]",
        "pubDate": "2026-02-03T01:54:26Z",
        "displayTime": "2026-02-03T01:54:26Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/91d6221e3df11e4933938a3082c41da1",
          "originalWidth": 949,
          "originalHeight": 505,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qbitK_60Vc8oncBc9nQEQw--~B/aD01MDU7dz05NDk7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/91d6221e3df11e4933938a3082c41da1.cf.webp",
              "width": 949,
              "height": 505,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wtjhuWw_GHJ65_98O46.rg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/91d6221e3df11e4933938a3082c41da1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/c4-therapeutics-inc-cccc-bull-015426512.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/c4-therapeutics-inc-cccc-bull-015426512.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CCCC"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "BIIB"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T01:08:48+00:00",
    "headline": "Pfizer Taps Novavax Matrix-M To Refresh Vaccine Growth Story",
    "summary": "Pfizer, NYSE:PFE, has entered a global licensing agreement with Novavax to use Matrix-M adjuvant technology in the development of up to two infectious disease vaccines. The deal grants Pfizer non-exclusive worldwide rights and immediate control over research, development, and commercialization for these Matrix-M based candidates. Financial terms include an upfront payment, potential future milestone payments, and tiered royalties linked to product sales. Pfizer comes into this agreement...",
    "url": "https://finance.yahoo.com/news/pfizer-taps-novavax-matrix-m-010848329.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "683c5af6-c445-3335-a02d-e524c12dc7cb",
      "content": {
        "id": "683c5af6-c445-3335-a02d-e524c12dc7cb",
        "contentType": "STORY",
        "title": "Pfizer Taps Novavax Matrix-M To Refresh Vaccine Growth Story",
        "description": "",
        "summary": "Pfizer, NYSE:PFE, has entered a global licensing agreement with Novavax to use Matrix-M adjuvant technology in the development of up to two infectious disease vaccines. The deal grants Pfizer non-exclusive worldwide rights and immediate control over research, development, and commercialization for these Matrix-M based candidates. Financial terms include an upfront payment, potential future milestone payments, and tiered royalties linked to product sales. Pfizer comes into this agreement...",
        "pubDate": "2026-02-03T01:08:48Z",
        "displayTime": "2026-02-03T01:08:48Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QSfydsi7Q.1zNEN99DbEyw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hi2p7oczHh8yTJraqZcczg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-taps-novavax-matrix-m-010848329.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-taps-novavax-matrix-m-010848329.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NVAX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T00:32:25+00:00",
    "headline": "Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory",
    "summary": "We came across a bullish thesis on Achieve Life Sciences, Inc. on Hunterbrook’s Substack. In this article, we will summarize the bulls’ thesis on ACHV. Achieve Life Sciences, Inc.’s share was trading at $4.18 as of January 30th. Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the […]",
    "url": "https://finance.yahoo.com/news/achieve-life-sciences-inc-achv-003225191.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "a22dfa67-759e-3c66-935d-83fff69c29ca",
      "content": {
        "id": "a22dfa67-759e-3c66-935d-83fff69c29ca",
        "contentType": "STORY",
        "title": "Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory",
        "description": "",
        "summary": "We came across a bullish thesis on Achieve Life Sciences, Inc. on Hunterbrook’s Substack. In this article, we will summarize the bulls’ thesis on ACHV. Achieve Life Sciences, Inc.’s share was trading at $4.18 as of January 30th. Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the […]",
        "pubDate": "2026-02-03T00:32:25Z",
        "displayTime": "2026-02-03T00:32:25Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/5e8b993356cd39a665654ae73d6f21b2",
          "originalWidth": 749,
          "originalHeight": 600,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/iLXPnbLixgbu7HLg88EG3A--~B/aD02MDA7dz03NDk7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/5e8b993356cd39a665654ae73d6f21b2.cf.webp",
              "width": 749,
              "height": 600,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FUe6qiNfEaOYihq26Oq6OQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/5e8b993356cd39a665654ae73d6f21b2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/achieve-life-sciences-inc-achv-003225191.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/achieve-life-sciences-inc-achv-003225191.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ACHV"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "GSK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T08:39:08+00:00",
    "headline": "Stocks to Watch Tuesday: Palantir, Teradyne, AMD",
    "summary": "↗️ Palantir (PLTR): The data company reported higher-than-expected earnings, as strong demand for its AI technology fueled another quarter of record revenue. Palantir stock jumped 5% in offhours trading.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-02-03-2026/card/stocks-to-watch-tuesday-palantir-teradyne-amd-1M4ooWKZ5ukuV7KWaO2N?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "9234fa62-b0cf-3ed2-ba67-8ebb3210dc74",
      "content": {
        "id": "9234fa62-b0cf-3ed2-ba67-8ebb3210dc74",
        "contentType": "STORY",
        "title": "Stocks to Watch Tuesday: Palantir, Teradyne, AMD",
        "description": "",
        "summary": "↗️ Palantir (PLTR): The data company reported higher-than-expected earnings, as strong demand for its AI technology fueled another quarter of record revenue. Palantir stock jumped 5% in offhours trading.",
        "pubDate": "2026-02-03T08:39:08Z",
        "displayTime": "2026-02-03T08:39:08Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/9234fa62-b0cf-3ed2-ba67-8ebb3210dc74/stocks-to-watch-tuesday-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/fe9cf9b29494c1d830c92dcb407f4127",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/007TBBbPiTfDjleSwZDKyg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/fe9cf9b29494c1d830c92dcb407f4127.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OcdPBlat2RDzV7EuOEo3wA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/fe9cf9b29494c1d830c92dcb407f4127.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-02-03-2026/card/stocks-to-watch-tuesday-palantir-teradyne-amd-1M4ooWKZ5ukuV7KWaO2N?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "TER"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "NXPI"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MDLZ"
            },
            {
              "symbol": "PEP"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T08:01:46+00:00",
    "headline": "Big Tech and Pharma Earnings: What to Watch This Week",
    "summary": "Earnings season marches on. Two more Magnificent Seven tech companies—Alphabet and Amazon—will report, following on the heels of disappointing results from Microsoft that helped send software stocks tumbling last week.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-02-03-2026/card/big-tech-and-pharma-earnings-what-to-watch-this-week-GbHxCGzyw4fBM6MvY1Vt?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "438e74ab-57b8-37a1-bea0-98d968b92710",
      "content": {
        "id": "438e74ab-57b8-37a1-bea0-98d968b92710",
        "contentType": "STORY",
        "title": "Big Tech and Pharma Earnings: What to Watch This Week",
        "description": "",
        "summary": "Earnings season marches on. Two more Magnificent Seven tech companies—Alphabet and Amazon—will report, following on the heels of disappointing results from Microsoft that helped send software stocks tumbling last week.",
        "pubDate": "2026-02-03T08:01:46Z",
        "displayTime": "2026-02-03T08:01:46Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/438e74ab-57b8-37a1-bea0-98d968b92710/big-tech-and-pharma-earnings-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/e6cec99e9a9c923e176c2b256dd003f8",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/WrpLbN9EPkBkY5Q7DEqcow--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/e6cec99e9a9c923e176c2b256dd003f8.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6T87T9eSRa4Fs4LKL4AqeA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/e6cec99e9a9c923e176c2b256dd003f8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-02-03-2026/card/big-tech-and-pharma-earnings-what-to-watch-this-week-GbHxCGzyw4fBM6MvY1Vt?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "GOOG"
            },
            {
              "symbol": "AMZN"
            },
            {
              "symbol": "MSFT"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "MDLZ"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "QCOM"
            },
            {
              "symbol": "SAN"
            },
            {
              "symbol": "UBER"
            },
            {
              "symbol": "PEP"
            },
            {
              "symbol": "BSX"
            },
            {
              "symbol": "NVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T10:25:00+00:00",
    "headline": "These Stocks Are Today’s Movers: Palantir, Teradyne, Tesla, AMD, NXP Semiconductors, and More",
    "summary": "Stock futures were rising Tuesday as Palantir’s strong earnings injected renewed optimism around the artificial-intelligence trade.  Palantir Technologies  jumped 10% in premarket trading after the company, which sells artificial-intelligence software to manage and analyze large amounts of data, reported better-than expected fourth-quarter adjusted earnings.  Revenue jumped 70% from a year earlier to a record $1.41 billion on strong demand for its AI technology.",
    "url": "https://www.barrons.com/articles/stock-movers-8b93e9b4?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "e9fc8b56-cb47-3ea3-b443-ba365c4733a4",
      "content": {
        "id": "e9fc8b56-cb47-3ea3-b443-ba365c4733a4",
        "contentType": "STORY",
        "title": "These Stocks Are Today’s Movers: Palantir, Teradyne, Tesla, AMD, NXP Semiconductors, and More",
        "description": "",
        "summary": "Stock futures were rising Tuesday as Palantir’s strong earnings injected renewed optimism around the artificial-intelligence trade.  Palantir Technologies  jumped 10% in premarket trading after the company, which sells artificial-intelligence software to manage and analyze large amounts of data, reported better-than expected fourth-quarter adjusted earnings.  Revenue jumped 70% from a year earlier to a record $1.41 billion on strong demand for its AI technology.",
        "pubDate": "2026-02-03T10:25:00Z",
        "displayTime": "2026-02-03T10:25:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/e9fc8b56-cb47-3ea3-b443-ba365c4733a4/these-stocks-are-today%E2%80%99s.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/5e6964a52dd39c379f4d464ca10273a4",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UEXjlWQWU_hzKOejLcC4Zw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/5e6964a52dd39c379f4d464ca10273a4.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/s4TWX16tW1HmSVkBOJ5DTg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/5e6964a52dd39c379f4d464ca10273a4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/stock-movers-8b93e9b4?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "TER"
            },
            {
              "symbol": "TSLA"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "NXPI"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T10:12:01+00:00",
    "headline": "Goldman Sachs Maintains Neutral on Pfizer (PFE) Amid Rising Margin Pressure",
    "summary": "Pfizer Inc. (NYSE:PFE) ranks among the stocks with the lowest forward PE ratios. On January 23, Goldman Sachs reaffirmed its Neutral rating and $26 price target on Pfizer Inc. (NYSE:PFE), citing the pharma giant’s key hurdles. Pfizer is facing the first of three years of rising patent-cliff strain on its profit margins, as its business […]",
    "url": "https://finance.yahoo.com/news/goldman-sachs-maintains-neutral-pfizer-101201749.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "6d5757bb-d8c9-3b06-8677-e6d5f7f12df7",
      "content": {
        "id": "6d5757bb-d8c9-3b06-8677-e6d5f7f12df7",
        "contentType": "STORY",
        "title": "Goldman Sachs Maintains Neutral on Pfizer (PFE) Amid Rising Margin Pressure",
        "description": "",
        "summary": "Pfizer Inc. (NYSE:PFE) ranks among the stocks with the lowest forward PE ratios. On January 23, Goldman Sachs reaffirmed its Neutral rating and $26 price target on Pfizer Inc. (NYSE:PFE), citing the pharma giant’s key hurdles. Pfizer is facing the first of three years of rising patent-cliff strain on its profit margins, as its business […]",
        "pubDate": "2026-02-03T10:12:01Z",
        "displayTime": "2026-02-03T10:12:01Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/53fde57e3df2e60396843254655c57ca",
          "originalWidth": 800,
          "originalHeight": 480,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6WTGkeph75pOVhavnybpiw--~B/aD00ODA7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/53fde57e3df2e60396843254655c57ca.cf.webp",
              "width": 800,
              "height": 480,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DK4Jv.eKjvFvm3Ar9OASuQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/53fde57e3df2e60396843254655c57ca.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/goldman-sachs-maintains-neutral-pfizer-101201749.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/goldman-sachs-maintains-neutral-pfizer-101201749.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T11:20:43+00:00",
    "headline": "Tech Bulls Rule Equities Pre-Bell; Asia Surges, Europe Gains",
    "summary": "Wall Street futures pointed moderately higher pre-bell Tuesday, following record-breaking rallies ov",
    "url": "https://finance.yahoo.com/news/tech-bulls-rule-equities-pre-112043172.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "b5ae9073-06f9-3e42-a226-c0542f0e5087",
      "content": {
        "id": "b5ae9073-06f9-3e42-a226-c0542f0e5087",
        "contentType": "STORY",
        "title": "Tech Bulls Rule Equities Pre-Bell; Asia Surges, Europe Gains",
        "description": "",
        "summary": "Wall Street futures pointed moderately higher pre-bell Tuesday, following record-breaking rallies ov",
        "pubDate": "2026-02-03T11:20:43Z",
        "displayTime": "2026-02-03T11:20:43Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/tech-bulls-rule-equities-pre-112043172.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/tech-bulls-rule-equities-pre-112043172.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "TER"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "PLTR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T12:32:36+00:00",
    "headline": "Stocks to Watch Tuesday: PayPal, PepsiCo, AMD",
    "summary": "↘️ Pfizer (PFE): The drugmaker reported lower quarterly sales and swung to a loss, as demand for its Covid-19 vaccine and antiviral drug continued to decline. Shares lost about 1% in premarket trading.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-02-03-2026/card/stocks-to-watch-tuesday-palantir-teradyne-amd-1M4ooWKZ5ukuV7KWaO2N?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "9234fa62-b0cf-3ed2-ba67-8ebb3210dc74",
      "content": {
        "id": "9234fa62-b0cf-3ed2-ba67-8ebb3210dc74",
        "contentType": "STORY",
        "title": "Stocks to Watch Tuesday: PayPal, PepsiCo, AMD",
        "description": "",
        "summary": "↘️ Pfizer (PFE): The drugmaker reported lower quarterly sales and swung to a loss, as demand for its Covid-19 vaccine and antiviral drug continued to decline. Shares lost about 1% in premarket trading.",
        "pubDate": "2026-02-03T12:32:36Z",
        "displayTime": "2026-02-03T12:32:36Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/9234fa62-b0cf-3ed2-ba67-8ebb3210dc74/stocks-to-watch-tuesday-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/fe9cf9b29494c1d830c92dcb407f4127",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/007TBBbPiTfDjleSwZDKyg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/fe9cf9b29494c1d830c92dcb407f4127.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OcdPBlat2RDzV7EuOEo3wA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/fe9cf9b29494c1d830c92dcb407f4127.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-02-03-2026/card/stocks-to-watch-tuesday-palantir-teradyne-amd-1M4ooWKZ5ukuV7KWaO2N?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PEP"
            },
            {
              "symbol": "PYPL"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NXPI"
            },
            {
              "symbol": "AMD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T12:24:01+00:00",
    "headline": "Jim Cramer Expresses Concern About Pfizer Despite Its “Terrific Yield”",
    "summary": "Pfizer Inc. (NYSE:PFE) is one of the stocks on Jim Cramer’s recent game plan. Cramer had mixed feelings about the stock, as he stated: On the other hand, I worry about Pfizer because while its stock has a terrific yield, I haven’t seen anything of late that would make me feel there’s a new blockbuster […]",
    "url": "https://finance.yahoo.com/news/jim-cramer-expresses-concern-pfizer-122401373.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "c6643f2d-9519-309d-b612-8321f4d78f28",
      "content": {
        "id": "c6643f2d-9519-309d-b612-8321f4d78f28",
        "contentType": "STORY",
        "title": "Jim Cramer Expresses Concern About Pfizer Despite Its “Terrific Yield”",
        "description": "",
        "summary": "Pfizer Inc. (NYSE:PFE) is one of the stocks on Jim Cramer’s recent game plan. Cramer had mixed feelings about the stock, as he stated: On the other hand, I worry about Pfizer because while its stock has a terrific yield, I haven’t seen anything of late that would make me feel there’s a new blockbuster […]",
        "pubDate": "2026-02-03T12:24:01Z",
        "displayTime": "2026-02-03T12:24:01Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/bede06ab4149315d5115f133c0b1480c",
          "originalWidth": 1920,
          "originalHeight": 1272,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lBNvOkwEcDTC6JSi8u6u5Q--~B/aD0xMjcyO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/bede06ab4149315d5115f133c0b1480c.cf.webp",
              "width": 1920,
              "height": 1272,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/l4R272WQ4gg_U7DbC5QzrA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/bede06ab4149315d5115f133c0b1480c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-expresses-concern-pfizer-122401373.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-expresses-concern-pfizer-122401373.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "VZ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T12:23:58+00:00",
    "headline": "Jim Cramer on PepsiCo’s Recent Rally: “Maybe Something’s Going On”",
    "summary": "PepsiCo, Inc. (NASDAQ:PEP) is one of the stocks on Jim Cramer’s recent game plan. Cramer highlighted the company’s snack division struggling due to GLP-1 drugs, as he remarked: Now, Tuesday’s filled with high-profile companies like PepsiCo, Merck, and Pfizer in the morning. I worry about PepsiCo because of its snack division, Frito-Lay. It’s struggling, a […]",
    "url": "https://finance.yahoo.com/news/jim-cramer-pepsico-recent-rally-122358142.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "6023adf5-ec6f-3b6f-a7e9-24d2344572d7",
      "content": {
        "id": "6023adf5-ec6f-3b6f-a7e9-24d2344572d7",
        "contentType": "STORY",
        "title": "Jim Cramer on PepsiCo’s Recent Rally: “Maybe Something’s Going On”",
        "description": "",
        "summary": "PepsiCo, Inc. (NASDAQ:PEP) is one of the stocks on Jim Cramer’s recent game plan. Cramer highlighted the company’s snack division struggling due to GLP-1 drugs, as he remarked: Now, Tuesday’s filled with high-profile companies like PepsiCo, Merck, and Pfizer in the morning. I worry about PepsiCo because of its snack division, Frito-Lay. It’s struggling, a […]",
        "pubDate": "2026-02-03T12:23:58Z",
        "displayTime": "2026-02-03T12:23:58Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/a9629676c8eff8f7c06e15cab8736cf0",
          "originalWidth": 1920,
          "originalHeight": 1920,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/alJ9aXwLsI8eioz.7SFMbQ--~B/aD0xOTIwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/a9629676c8eff8f7c06e15cab8736cf0.cf.webp",
              "width": 1920,
              "height": 1920,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qmmKzST5gH9bvAtpNqsXRA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/a9629676c8eff8f7c06e15cab8736cf0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-pepsico-recent-rally-122358142.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-pepsico-recent-rally-122358142.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PEP"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T12:21:00+00:00",
    "headline": "Pfizer Sales Fall on Continued Lower Covid-19 Drug Demand",
    "summary": "Pfizer reported lower fourth-quarter sales as demand for its Covid-19 vaccine and antiviral drug continued to decline.",
    "url": "https://www.wsj.com/business/earnings/pfizer-sales-fall-on-continued-lower-covid-19-drug-demand-02fee757?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "446ae706-40f8-3629-8698-66e1e0a3131a",
      "content": {
        "id": "446ae706-40f8-3629-8698-66e1e0a3131a",
        "contentType": "STORY",
        "title": "Pfizer Sales Fall on Continued Lower Covid-19 Drug Demand",
        "description": "",
        "summary": "Pfizer reported lower fourth-quarter sales as demand for its Covid-19 vaccine and antiviral drug continued to decline.",
        "pubDate": "2026-02-03T12:21:00Z",
        "displayTime": "2026-02-03T12:21:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/446ae706-40f8-3629-8698-66e1e0a3131a/pfizer-sales-fall-on.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/3b6774ea810b8f54759159222b795648",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yHjLxewpFGrzQE7iCtUZFQ--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/3b6774ea810b8f54759159222b795648.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bJVENmQP35_X8rYjPcVNrg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/3b6774ea810b8f54759159222b795648.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/business/earnings/pfizer-sales-fall-on-continued-lower-covid-19-drug-demand-02fee757?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "FDS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T12:19:40+00:00",
    "headline": "Pfizer (NYSE:PFE) Posts Better-Than-Expected Sales In Q4 CY2025",
    "summary": "Global pharmaceutical company Pfizer (NYSE:PFE) announced better-than-expected revenue in Q4 CY2025, but sales fell by 1.2% year on year to $17.56 billion. The company expects the full year’s revenue to be around $61 billion, close to analysts’ estimates. Its non-GAAP profit of $0.66 per share was 16.2% above analysts’ consensus estimates.",
    "url": "https://finance.yahoo.com/news/pfizer-nyse-pfe-posts-better-121940316.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "22df918a-e900-354c-91c1-661e76947075",
      "content": {
        "id": "22df918a-e900-354c-91c1-661e76947075",
        "contentType": "STORY",
        "title": "Pfizer (NYSE:PFE) Posts Better-Than-Expected Sales In Q4 CY2025",
        "description": "",
        "summary": "Global pharmaceutical company Pfizer (NYSE:PFE) announced better-than-expected revenue in Q4 CY2025, but sales fell by 1.2% year on year to $17.56 billion. The company expects the full year’s revenue to be around $61 billion, close to analysts’ estimates. Its non-GAAP profit of $0.66 per share was 16.2% above analysts’ consensus estimates.",
        "pubDate": "2026-02-03T12:19:40Z",
        "displayTime": "2026-02-03T12:19:40Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/1ff5bd386bd84b91b34108fd5f310eca",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "PFE Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/o3tZoPUio75qXATbHoc_Hg--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/1ff5bd386bd84b91b34108fd5f310eca.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/o5rZqD7vIoFGnsFYAS_Ztw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/1ff5bd386bd84b91b34108fd5f310eca.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-nyse-pfe-posts-better-121940316.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-nyse-pfe-posts-better-121940316.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T12:16:17+00:00",
    "headline": "Stocks Mostly Rise Pre-Bell as Investors Await Latest Round of Corporate Earnings",
    "summary": "US equity futures were mostly pointing higher on Tuesday as traders await a fresh batch of corporate",
    "url": "https://finance.yahoo.com/news/stocks-mostly-rise-pre-bell-121617545.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "36c8c3ff-12fb-31be-8c10-4a8d88132e3c",
      "content": {
        "id": "36c8c3ff-12fb-31be-8c10-4a8d88132e3c",
        "contentType": "STORY",
        "title": "Stocks Mostly Rise Pre-Bell as Investors Await Latest Round of Corporate Earnings",
        "description": "",
        "summary": "US equity futures were mostly pointing higher on Tuesday as traders await a fresh batch of corporate",
        "pubDate": "2026-02-03T12:16:17Z",
        "displayTime": "2026-02-03T12:16:17Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/mt_newswires_premium_news_706/8685121785649cec3dbcdbbd25333a86",
          "originalWidth": 1024,
          "originalHeight": 683,
          "caption": "wall street stock market flag new york trading equity - Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QVMgErJdOR7IkzCjRHm3pQ--~B/aD02ODM7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/mt_newswires_premium_news_706/8685121785649cec3dbcdbbd25333a86.cf.webp",
              "width": 1024,
              "height": 683,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dimQxOClk1isv1IKNf9JtA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/mt_newswires_premium_news_706/8685121785649cec3dbcdbbd25333a86.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/stocks-mostly-rise-pre-bell-121617545.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/stocks-mostly-rise-pre-bell-121617545.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TER"
            },
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "NXPI"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "ITW"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "MDLZ"
            },
            {
              "symbol": "CMG"
            },
            {
              "symbol": "EA"
            },
            {
              "symbol": "TDG"
            },
            {
              "symbol": "PYPL"
            },
            {
              "symbol": "ADM"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "EMR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T12:10:09+00:00",
    "headline": "Assessing Pfizer (PFE) Valuation After Recent Share Price Rebound And Oncology Expansion",
    "summary": "What Pfizer’s recent performance tells you right now Pfizer (PFE) has drawn fresh attention after a period in which the share price has moved higher over the past week, month and past 3 months, putting recent returns in clearer focus for investors. See our latest analysis for Pfizer. That recent 1 month share price return of 5.88% and 3 month share price return of 9.71% sit against a 1 year total shareholder return of 9.14%. The 3 year total shareholder return of a 26.99% decline shows that...",
    "url": "https://finance.yahoo.com/news/assessing-pfizer-pfe-valuation-recent-121009659.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "ca51cd6e-e487-3d24-80e2-128a35bd3f80",
      "content": {
        "id": "ca51cd6e-e487-3d24-80e2-128a35bd3f80",
        "contentType": "STORY",
        "title": "Assessing Pfizer (PFE) Valuation After Recent Share Price Rebound And Oncology Expansion",
        "description": "",
        "summary": "What Pfizer’s recent performance tells you right now Pfizer (PFE) has drawn fresh attention after a period in which the share price has moved higher over the past week, month and past 3 months, putting recent returns in clearer focus for investors. See our latest analysis for Pfizer. That recent 1 month share price return of 5.88% and 3 month share price return of 9.71% sit against a 1 year total shareholder return of 9.14%. The 3 year total shareholder return of a 26.99% decline shows that...",
        "pubDate": "2026-02-03T12:10:09Z",
        "displayTime": "2026-02-03T12:10:09Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QSfydsi7Q.1zNEN99DbEyw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hi2p7oczHh8yTJraqZcczg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/assessing-pfizer-pfe-valuation-recent-121009659.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/assessing-pfizer-pfe-valuation-recent-121009659.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T12:02:00+00:00",
    "headline": "Pfizer Stock Falls After Solid Earnings. What’s Troubling Wall Street.",
    "summary": "Pfizer also releases positive top-line results from a trial for its injectable GLP-1 receptor agonist in adults with obesity.",
    "url": "https://www.barrons.com/articles/pfizer-earnings-stock-price-cbedad25?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "68e4cf30-fe16-33ac-ab8c-b0fbd82fb7fd",
      "content": {
        "id": "68e4cf30-fe16-33ac-ab8c-b0fbd82fb7fd",
        "contentType": "STORY",
        "title": "Pfizer Stock Falls After Solid Earnings. What’s Troubling Wall Street.",
        "description": "",
        "summary": "Pfizer also releases positive top-line results from a trial for its injectable GLP-1 receptor agonist in adults with obesity.",
        "pubDate": "2026-02-03T12:02:00Z",
        "displayTime": "2026-02-03T12:02:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/68e4cf30-fe16-33ac-ab8c-b0fbd82fb7fd/pfizer-stock-falls-after.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/4608287e543057b8e3564d86f34a7cc8",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Fny.jtxShojEWkQQLFwTUA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/4608287e543057b8e3564d86f34a7cc8.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Yy183Pf3MkMrY0jrwFrVcQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/4608287e543057b8e3564d86f34a7cc8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/pfizer-earnings-stock-price-cbedad25?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "FDS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T12:00:58+00:00",
    "headline": "Pfizer beats fourth-quarter profit estimates on strong drug demand",
    "summary": "Feb 3(Reuters) - Pfizer on Tuesday reported fourth-quarter profit above Wall Street estimates, as sustained demand for older drugs such as blood thinner Eliquis helped offset fading sales of its COVID",
    "url": "https://finance.yahoo.com/news/pfizer-beats-fourth-quarter-profit-115248423.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "3f68cef5-df93-3b6e-a79a-4bf7cf4c0c52",
      "content": {
        "id": "3f68cef5-df93-3b6e-a79a-4bf7cf4c0c52",
        "contentType": "STORY",
        "title": "Pfizer beats fourth-quarter profit estimates on strong drug demand",
        "description": "",
        "summary": "Feb 3(Reuters) - Pfizer on Tuesday reported fourth-quarter profit above Wall Street estimates, as sustained demand for older drugs such as blood thinner Eliquis helped offset fading sales of its COVID",
        "pubDate": "2026-02-03T12:00:58Z",
        "displayTime": "2026-02-03T12:00:58Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/76d545bba934786e3320b25c0a241d2c",
          "originalWidth": 800,
          "originalHeight": 533,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4HShWbfmNDVhWU6f2_w_vw--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/76d545bba934786e3320b25c0a241d2c.cf.webp",
              "width": 800,
              "height": 533,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jFCL1PV3fPW0TupGx0dh7g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/76d545bba934786e3320b25c0a241d2c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-beats-fourth-quarter-profit-115248423.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-beats-fourth-quarter-profit-115248423.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T11:53:27+00:00",
    "headline": "Pfizer: Q4 Earnings Snapshot",
    "summary": "NEW YORK (AP) — Pfizer Inc. PFE) on Tuesday reported a loss of $1.65 billion in its fourth quarter. On a per-share basis, the New York-based company said it had a loss of 29 cents.",
    "url": "https://finance.yahoo.com/news/pfizer-q4-earnings-snapshot-115327218.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "f40a7614-3b64-3a92-b915-099056ea390f",
      "content": {
        "id": "f40a7614-3b64-3a92-b915-099056ea390f",
        "contentType": "STORY",
        "title": "Pfizer: Q4 Earnings Snapshot",
        "description": "",
        "summary": "NEW YORK (AP) — Pfizer Inc. PFE) on Tuesday reported a loss of $1.65 billion in its fourth quarter. On a per-share basis, the New York-based company said it had a loss of 29 cents.",
        "pubDate": "2026-02-03T11:53:27Z",
        "displayTime": "2026-02-03T11:53:27Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-q4-earnings-snapshot-115327218.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-q4-earnings-snapshot-115327218.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T11:45:00+00:00",
    "headline": "Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance",
    "summary": "NEW YORK, February 03, 2026--PFE Q4 2025 Earnings Release",
    "url": "https://finance.yahoo.com/news/pfizer-reports-solid-full-2025-114500250.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "b267aaa9-61cc-3ab8-aa91-4f329d455df0",
      "content": {
        "id": "b267aaa9-61cc-3ab8-aa91-4f329d455df0",
        "contentType": "STORY",
        "title": "Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance",
        "description": "",
        "summary": "NEW YORK, February 03, 2026--PFE Q4 2025 Earnings Release",
        "pubDate": "2026-02-03T11:45:00Z",
        "displayTime": "2026-02-03T11:45:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/8a7baf4c0dffff29ec99d62e26d096eb",
          "originalWidth": 480,
          "originalHeight": 212,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XcqSRAF_EK7UyCMyQFvZNA--~B/aD0yMTI7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/8a7baf4c0dffff29ec99d62e26d096eb.cf.webp",
              "width": 480,
              "height": 212,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cM.vExG7ROIgvv8UyeD.WQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/8a7baf4c0dffff29ec99d62e26d096eb.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-reports-solid-full-2025-114500250.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-reports-solid-full-2025-114500250.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "TRSBF"
            },
            {
              "symbol": "ONPH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T11:40:00+00:00",
    "headline": "Pfizer’s Ultra-Long-Acting Injectable GLP-1 RA Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial",
    "summary": "NEW YORK, February 03, 2026--Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 2b VESPER-3 study investigating monthly maintenance dosing of its fully-biased, ultra-long-acting, injectable GLP-1 receptor agonist (RA) PF’3944 (MET-097i) in adults with obesity or overweight without type 2 diabetes. The study had two objectives:",
    "url": "https://finance.yahoo.com/news/pfizer-ultra-long-acting-injectable-114000072.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "dc93af6c-4528-3fab-972f-fd06ad90958a",
      "content": {
        "id": "dc93af6c-4528-3fab-972f-fd06ad90958a",
        "contentType": "STORY",
        "title": "Pfizer’s Ultra-Long-Acting Injectable GLP-1 RA Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial",
        "description": "",
        "summary": "NEW YORK, February 03, 2026--Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 2b VESPER-3 study investigating monthly maintenance dosing of its fully-biased, ultra-long-acting, injectable GLP-1 receptor agonist (RA) PF’3944 (MET-097i) in adults with obesity or overweight without type 2 diabetes. The study had two objectives:",
        "pubDate": "2026-02-03T11:40:00Z",
        "displayTime": "2026-02-03T11:40:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/a654442abb5efb738aaf782af8d9564e",
          "originalWidth": 480,
          "originalHeight": 212,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/oXCpOIpdYH5brCDZDNOuBQ--~B/aD0yMTI7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/a654442abb5efb738aaf782af8d9564e.cf.webp",
              "width": 480,
              "height": 212,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/oOWu1Ymsgyd1pzoCcBjxng--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/a654442abb5efb738aaf782af8d9564e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-ultra-long-acting-injectable-114000072.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-ultra-long-acting-injectable-114000072.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T11:09:00+00:00",
    "headline": "These Stocks Are Today’s Movers: Palantir, Teradyne, Tesla, PepsiCo, AMD, NXP Semiconductors, and More",
    "summary": "Stock futures were rising Tuesday as strong earnings from Palantir Technologies injected renewed optimism around the artificial-intelligence trade.  Palantir Technologies  jumped 11% in premarket trading after the company, which sells artificial-intelligence software to manage and analyze large amounts of data, reported better-than expected fourth-quarter adjusted earnings.  Revenue jumped 70% from a year earlier to a record $1.41 billion on strong demand for its AI technology.",
    "url": "https://www.barrons.com/articles/stock-movers-8b93e9b4?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "e9fc8b56-cb47-3ea3-b443-ba365c4733a4",
      "content": {
        "id": "e9fc8b56-cb47-3ea3-b443-ba365c4733a4",
        "contentType": "STORY",
        "title": "These Stocks Are Today’s Movers: Palantir, Teradyne, Tesla, PepsiCo, AMD, NXP Semiconductors, and More",
        "description": "",
        "summary": "Stock futures were rising Tuesday as strong earnings from Palantir Technologies injected renewed optimism around the artificial-intelligence trade.  Palantir Technologies  jumped 11% in premarket trading after the company, which sells artificial-intelligence software to manage and analyze large amounts of data, reported better-than expected fourth-quarter adjusted earnings.  Revenue jumped 70% from a year earlier to a record $1.41 billion on strong demand for its AI technology.",
        "pubDate": "2026-02-03T11:09:00Z",
        "displayTime": "2026-02-03T11:09:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/e9fc8b56-cb47-3ea3-b443-ba365c4733a4/these-stocks-are-today%E2%80%99s.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/5e6964a52dd39c379f4d464ca10273a4",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UEXjlWQWU_hzKOejLcC4Zw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/5e6964a52dd39c379f4d464ca10273a4.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/s4TWX16tW1HmSVkBOJ5DTg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/5e6964a52dd39c379f4d464ca10273a4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/stock-movers-8b93e9b4?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "TER"
            },
            {
              "symbol": "TSLA"
            },
            {
              "symbol": "PEP"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "NXPI"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]